Bit.bio makes two big announcements in Alzheimer’s and Parkinson’s research and collaboration

Portfolio company bit.bio made two big announcements.  In addition to launching a panel of 16 opti-ox™ precision reprogrammed neurodegenerative disease models for research and drug discovery in Alzheimer’s and Parkinson’s, they announced the first project in a multi-year collaboration agreement with the Michael J. Fox Foundation for Parkinson's Research to generate human cell products for research, and drug discovery in these areas.